Download Chapter 6 CARDIOVASCULAR ARRHYTHMIAS AND

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Chapter 6
Drugs for
Cardiovascular
Arrhythmias and
Hypertension
1
 Hank Gathers
 hypertrophic cardiomyopathy
 Flo Hyman
 Marfan’s syndrome
 Jim Fixx
 atherosclerotic coronary artery disease
 Darryl Kile
 atherosclerotic coronary artery disease
2
 “Pistol” Pete Maravich
 abnormal coronary arteries
 Len Bias
 illegal drugs
 High School versus College Athlete
 Changing cardiovascular development
3
Arrhythmias
 “Irregular heart action caused by
physiological or pathological
disturbances in the discharge of cardiac
impulses from the sinoatrial node or their
transmission through conductive tissue of
the heart.”
4
Arrhythmias
 Medications control arrhythmias and
assist the heart in maintaining a normal
rhythm
 Device-based techniques
 Implantable pacemakers or defibrillators
 Can result in syncope, fatal in certain
sports
 Table 6-1, pg 82
5
Arrhythmias
 Common Forms of Arrhythmias
 Table 6-2,pg 83
6
Arrhythmia Medications
 Four subclassifications




Class I
Class II
Class III
Class IV
Sodium channel blockers
β-adrenergic blockers
Potassium channel blockers
Calcium channel blockers
7
Adverse Effects






Lethargy
Fatigue
Bradycardia
Orthostatic hypotension
Cold extremities
Rashes, pruritus, headache, nausea,
diarrhea, swelling, behavioral
disturbances, disorientation
8
Adverse Effects (cont.)
 Despite the purpose of reducing
arrhythmias one of the most common
side effects of the anti arrhythmic drugs is
the increase in rhythm disturbances.
9
Antiarrhythmic Drug
Interactions
 Table 6-3, pg 85
10
Device Therapy
 Pacemakers – first implanted (1958)
 Implantable cardioverter defibrillators
(ICD) – (1980)
 Not common in athletes
11
Hypertension
 Hypertension is the “pressure in the
pipes”
 Diet, stress, genetics, etc.
 Approximately 24% of population
 Females have higher rates
 BP > 140 mm Hg
 on three separate occasions
 Essential hypertension
 No known cause
 Secondary hypertension
 Diagnosable cause
12
BP Classifications
 Normal
<120/<80
 Prehypertension 120 –139/80–89
 Hypertension
 Stage 1
 Stage 2
 Stage 3
140 – 159/90 – 99
>160/>100
Physician’s care
13
Monitor variables that can
affect BP
 Salt and intake of high-sodium and highfat foods (PJ)
 Alcohol
 Over-the-counter stimulants caffeine/cold medication
 Diet pills
 Smoking or chewing tobacco
 Cocaine or anabolic steroids
14
Medications for
Hypertension






Diuretics
Calcium channel blockers
ACE Inhibitors
Angiotensin II blockers
Beta blockers
Alpha-blockers
15
Adverse Effects
 Diuretics
 Orthostatic hypotension
 Dehydration – electrolyte imbalance
 ACE inhibitors
 Cough
 Beta blockers
 Bradycardia, fatigue, dizziness
 Alpha-blockers
 Tachycardia/orthostatic hypotension
16
Hypertension in the
Athlete/Active Population
 Table 6-6, pg 88
17
What to Tell the Athlete
 Page 88
18
Related documents